Clinical Trials Directory

Trials / Completed

CompletedNCT01023178

Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure

Comparison of Transdermal and Oral Estrogens in Adolescents With Ovarian Failure

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Stanford University · Academic / Other
Sex
Female
Age
12 Years – 18 Years
Healthy volunteers
Not accepted

Summary

To directly compare the safety (by laboratory evaluation) and efficacy (feminization and growth) of three commonly used estrogen preparations in adolescent patients with ovarian failure, either due to congenital causes (Turner syndrome) or medical therapies. We hypothesize that transdermal estrogen will have equivalent efficacy and a more favorable safety profile in comparison with conventional oral estrogen replacement.

Detailed description

Treatment with transdermal 17beta(17β) estradiol resulted in higher estradiol levels and more effective feminization compared to oral conjugated equine estrogen but did not result in an otherwise different biochemical profile in this limited number of heterogeneous patients. OBE (oral beta estradiol) and TBE (transdermal beta estradiol) provide safe and effective alternatives to OCEE (oral conjugated equine estrogen) to induce puberty in girls, but larger prospective randomized trials are required.

Conditions

Interventions

TypeNameDescription
DRUG17beta EstradiolOral pill given daily at increasing doses every 6 months for 18 months.
DRUGConjugated estrogensOral pill, started at a low dose taken daily, dose increased every 6 months for 18 months
DRUG17Beta Estradiol - transdermalTransdermal estrogen patch, started at low dose with increasing doses eery 6 months for 18 months
DRUGProgesterone, micronizedGiven starting at 18 months

Timeline

Start date
2007-02-01
Primary completion
2013-06-01
Completion
2013-06-01
First posted
2009-12-02
Last updated
2017-01-20
Results posted
2017-01-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01023178. Inclusion in this directory is not an endorsement.